Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Unknown status (1)

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Children's Hospital of Philadelphia (1)

Maria Sklodowska-Curie National Research Institute of Oncology (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Bristol-Myers Squibb (1)

Jazz Pharmaceuticals (1)

Stand Up To Cancer (1)

Intervention

hypofractionated radiotherapy (1)

lurbinectedin (1)

nivolumab (1)

sequential chemotherapy - 3 courses of ai (1)

Study Documents

Intervention Type

drug (3)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

undifferentiated sarcoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Pediatric Cancer Trial in Philadelphia (Lurbinectedin)

Not yet recruiting

Ewing Sarcoma
+3 more

Lurbinectedin

Philadelphia, Pennsylvania

Children's Hospital of Philadelphia

Jun 27, 2023

Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)

Active, not recruiting

Uterine Cancer
+6 more

Nivolumab

Basking Ridge, New Jersey
+7 more

Apr 4, 2022

Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

Unknown status

Sarcoma
+16 more

Sequential chemotherapy - 3 courses of AI
Hypofractionated radiotherapy

Warsaw, Mazovian, Poland

Maria Sklodowska-Curie Institute - Oncology Center

Jan 19, 2021